GlassScriptPhysician profile
Nancy S Gregory
NPI 1801954003
$392.55
in general payments reported to CMS, 2019-2025
10 companies · $36.65 in 2025
The $36.65 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.45 · 2022: $22.42 · 2023: $204 · 2024: $114 · 2025: $36.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $81.01 | 2023-2025 | Zeposia |
| Tandem Diabetes Care, INC. | $69.96 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $62.45 | 2021-2023 | Dexcom G6 Transmitter |
| Abbvie INC. | $32.67 | 2024 | |
| Lilly USA, LLC | $31.79 | 2023-2024 | Mounjaro, Zepbound |
| Novo Nordisk INC | $29.23 | 2023-2024 | Rybelsus, Ozempic |
| Sanofi Pasteur INC. | $26.86 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $22.47 | 2023 | Eliquis |
| Pfizer INC. | $20.82 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $15.29 | 2024 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Gregory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.